Home / Sweden / Alligator Bioscience AB
Alligator Bioscience AB
Short position disclosed on August 12, 2026.
1.78% of the capital sold short
1 disclosing funds
70 disclosures on record
SE0024173637 ISIN code
Evolution of the disclosed total
0%2%4%6%8%
Oct 2025Jan 2026Apr 2026Jul 2026
January 21, 2021 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Two Sigma Investments, LP | 1.78% | new | August 12, 2026 |
On the other side: the funds that hold Alligator Bioscience AB Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 24, 2025 | Millennium Capital Partners LLP | 1.20% | still open |
| January 22, 2025 | Rickard Rönblom | 0.61% | still open |
| January 17, 2025 | Rickard Rönblom | 0.85% | still open |
| June 9, 2023 | Guevoura Fund | 1.22% | still open |
| June 7, 2023 | Guevoura Fund | 1.13% | still open |
| June 2, 2023 | Guevoura Fund | 3.04% | still open |
| June 1, 2023 | Guevoura Fund | 2.94% | still open |
| May 31, 2023 | Guevoura Fund | 2.71% | still open |
| May 30, 2023 | Guevoura Fund | 2.47% | still open |
| May 26, 2023 | Guevoura Fund | 2.03% | still open |
| May 25, 2023 | Guevoura Fund | 1.88% | still open |
| May 24, 2023 | Guevoura Fund | 1.36% | still open |
| November 25, 2021 | LMR Partners LLP | 0.00% | still open |
| November 23, 2021 | LMR Partners LLP | 0.50% | still open |
| November 22, 2021 | LMR Partners LLP | 0.77% | still open |
| November 19, 2021 | LMR Partners LLP | 0.88% | still open |
| November 18, 2021 | LMR Partners LLP | 0.95% | still open |
| November 17, 2021 | LMR Partners LLP | 1.07% | still open |
| February 26, 2021 | Susquehanna International Holding LLC | 0.00% | still open |
| January 21, 2021 | Susquehanna International Holding LLC | 0.55% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Alligator Bioscience AB, source Finansinspektionen, data as at August 12, 2026, https://www.quivad.com/action/alligator-bioscience-ab?page=2